GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Price-to-Operating-Cash-Flow

Microba Life Sciences (ASX:MAP) Price-to-Operating-Cash-Flow : (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Price-to-Operating-Cash-Flow?

As of today (2024-06-06), Microba Life Sciences's share price is A$0.18. Microba Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05. Hence, Microba Life Sciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Microba Life Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:MAP's Price-to-Operating-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 17.84
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Microba Life Sciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05.

Microba Life Sciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Microba Life Sciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Price-to-Operating-Cash-Flow Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Price-to-Operating-Cash-Flow
- -

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow - - - - -

Competitive Comparison of Microba Life Sciences's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Microba Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microba Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Microba Life Sciences's Price-to-Operating-Cash-Flow falls into.


Microba Life Sciences Price-to-Operating-Cash-Flow Calculation

Microba Life Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.18/-0.054
=

Microba Life Sciences's Share Price of today is A$0.18.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Microba Life Sciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:GTG ASX:BDX ASX:IBX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX
Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Website
https://www.microba.com
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines